Lv41
700 积分 2021-10-13 加入
Molecular classification of hormone receptor-positive HER2-negative breast cancer
1小时前
已完结
Circulating Tumor Cell Dynamics after CDK4/6 Inhibitor for Hormone Receptor-Positive Metastatic Breast Cancer: A Biomarker Analysis from the PACE Phase II Study
1个月前
已完结
Prognostic significance of early on-treatment evolution of circulating tumor DNA in advanced ER-positive/HER2-negative breast cancer
1个月前
已完结
Towards targeting the breast cancer immune microenvironment
1个月前
已完结
AGEs induce MMP-9 promoter demethylation through the GADD45α-mediated BER pathway to promote breast cancer metastasis in patients with diabetes
1个月前
已完结
Tumor and Immune Dynamics Following Sequential CDK4/6 and PD-1 Inhibition: Results from a Phase 2 Study in Dedifferentiated Liposarcoma
1个月前
已完结
Co-targeting CDK4/6 enhances anti-cancer activity and alleviates immune-related adverse events of anti-PD-1 antibody for breast cancer
1个月前
已完结
CDK4/6 Inhibition Induces CD8+ T Cell Antitumor Immunity via MIF-Induced Functional Orchestration of Tumor-Associated Macrophages
1个月前
已完结
Recent advances in regulating the cell cycle through inhibiting CDKs for cancer treatment
1个月前
已完结
Post-progression treatment options after CDK4/6 inhibitors in hormone receptor-positive, HER2-negative metastatic breast cancer
1个月前
已完结
皖公网安备34019202002308
